Immune System News and Research

RSS

Researchers find priority targets for ovarian cancer immunotherapy

Researchers at Roswell Park Cancer Institute (RPCI) have found that the expression pattern of a unique class of tumor-associated antigens, known as the MAGE cancer-testis antigens (CTAs), correlates with clinical outcome in epithelial ovarian cancer.

14 Aug 2014

Babies suffering from life-threatening bacterial infections could benefit from improved treatment

Babies suffering from life-threatening bacterial infections such as sepsis could benefit from improved treatment, thanks to a ground-breaking study.

14 Aug 2014

Ebola virus defeats attempts by interferon to block viral reproduction in infected cells

One of the human body's first responses to a viral infection is to make and release signaling proteins called interferons, which amplify the immune system response to viruses.

14 Aug 2014

Injections of anaerobic bacteria can shrink tumors in rats, dogs and human

Deep within most tumors lie areas that remain untouched by chemotherapy and radiation. These troublesome spots lack the blood and oxygen needed for traditional therapies to work, but provide the perfect target for a new cancer treatment using bacteria that thrive in oxygen-poor conditions.

14 Aug 2014

Recurrence of breast cancer cut by ½ in overweight women who regularly use NSAIDs

Recurrence of hormone-related breast cancer was cut by half in overweight and obese women who regularly used aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs), according to data published in Cancer Research, a journal of the American Association for Cancer Research.

14 Aug 2014

Combination of NASBA and real-time qPCR detects aspergillosis with 100% accuracy

The fungal infection invasive aspergillosis (IA) can be life threatening, especially in patients whose immune systems are weakened by chemotherapy or immunosuppressive drugs. Despite the critical need for early detection, IA remains difficult to diagnose.

14 Aug 2014

Research and planning to meet health needs of people living with HIV

As effective treatments for HIV become more widely available in low- and middle-income countries, there's an urgent need to assess and manage health risks in the growing number of people living with HIV.

14 Aug 2014

MicroVAX begins phase I clinical trial for proprietary cancer vaccine platform

MicroVAX, LLC, a biotech company located in Manassas, Virginia announced today the commencement of a phase I clinical trial for its unique and proprietary vaccine platform that allows under the provisions of an FDA IND entry of patients with cancers of the, breast, prostate, colon, ovary and lung, that have relapsed after initial salvage therapy.

13 Aug 2014

High-dose influenza vaccine 24% more effective in older adults

High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications, according to a Vanderbilt-led study published today in the New England Journal of Medicine.

13 Aug 2014

Phase 2 study: Rigel's R348 fails to meet endpoints in patients with dry eye disease

Rigel Pharmaceuticals, Inc. today announced that R348, its ophthalmic JAK/SYK inhibitor, did not meet the primary or secondary endpoints in a recently completed Phase 2 clinical study in patients with dry eye disease.

13 Aug 2014

Prevalence of bacterial meningitis drops in the United States

Advances in the prevention and treatment of an often fatal condition called bacterial meningitis appear to be paying dividends in the United States, report infectious disease experts at The University of Texas Health Science Center at Houston (UTHealth) in the journal The Lancet Infectious Diseases.

13 Aug 2014

Research hopes to protect hundreds of newborns from severe health problems by protein in milk

An international effort led by the University of Sydney hopes to protect hundreds of Bangladeshi newborns from a host of severe health problems by assessing the effect of lactoferrin, a natural protein found in breast and cow's milk, in the treatment of iron deficiency anemia in pregnancy.

13 Aug 2014

Lung-damaging bacterium turns body's antibody response in its favor

A lung-damaging bacterium turns the body's antibody response in its favor, according to a study published in The Journal of Experimental Medicine.

13 Aug 2014

Natural gut bacterial community may affect intestinal function

Bacteria in the gut help the body to digest food, and stimulate the immune system. A PhD project at the National Food Institute, Technical University of Denmark, examines whether modulations of the gut bacterial composition affect intestinal integrity, i.e. the ability of the body to maintain a well-regulated barrier function that hinders bacteria from entering the body unintentionally.

13 Aug 2014

Epigenetics has a large say in blood formation

Blood stem cells have the potential to turn into any type of blood cell, whether it be the oxygen-carrying red blood cells, or the many types of white blood cells of the immune system that help fight infection.

12 Aug 2014

Prominent scientists to deliver scientific presentations at ACS meeting

The Kavli Foundation Lecture series today features two prominent scientists: one in the booming area of ionic liquids, the other in medical materials.

12 Aug 2014

Bee, snake, scorpion venom could form basis of new generation of cancer-fighting drugs

Bee, snake or scorpion venom could form the basis of a new generation of cancer-fighting drugs, scientists will report here today.

12 Aug 2014

New drug spurs liver regeneration after surgery

A new drug spurs liver regeneration after surgery, according to a paper published in The Journal of Experimental Medicine.

12 Aug 2014

Researchers discover how arginine starvation specifically kills cancer cells

Researchers at UC Davis, City of Hope, Taipai Medical University and National Health Research Institutes in Taiwan have discovered how a drug that deprives the cells of a key amino acid specifically kills cancer cells.

12 Aug 2014

Scientists aim to understand and treat painful bladder condition

Taking advantage of technology that can analyze tissue samples and measure the activity of thousands of genes at once, scientists at Wake Forest Baptist Medical Center are on a mission to better understand and treat interstitial cystitis (IC), a painful and difficult-to-diagnose bladder condition.

12 Aug 2014

Immune System News and Research

Researchers find priority targets for ovarian cancer immunotherapy

Babies suffering from life-threatening bacterial infections could benefit from improved treatment

Ebola virus defeats attempts by interferon to block viral reproduction in infected cells

Injections of anaerobic bacteria can shrink tumors in rats, dogs and human

Recurrence of breast cancer cut by ½ in overweight women who regularly use NSAIDs

Combination of NASBA and real-time qPCR detects aspergillosis with 100% accuracy

Research and planning to meet health needs of people living with HIV

MicroVAX begins phase I clinical trial for proprietary cancer vaccine platform

High-dose influenza vaccine 24% more effective in older adults

Phase 2 study: Rigel's R348 fails to meet endpoints in patients with dry eye disease

Prevalence of bacterial meningitis drops in the United States

Research hopes to protect hundreds of newborns from severe health problems by protein in milk

Lung-damaging bacterium turns body's antibody response in its favor

Natural gut bacterial community may affect intestinal function

Epigenetics has a large say in blood formation

Prominent scientists to deliver scientific presentations at ACS meeting

Bee, snake, scorpion venom could form basis of new generation of cancer-fighting drugs

New drug spurs liver regeneration after surgery

Researchers discover how arginine starvation specifically kills cancer cells

Scientists aim to understand and treat painful bladder condition

Understanding the DNA Damage Response in Innate Immunity eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News